Martin Felsenthal Overview
- Investor Type
- Angel
- Status
- Active
- Professionals
- 1
Martin Felsenthal General Information
Description
Mr. Martin Felsenthal serves as Partner at Health Velocity Capital. He also serves as a Board Member at WELL Health. He has worked exclusively with innovative, disruptive, and rapidly growing healthcare software and services companies for more than 20 years. He was previously a partner at two leading venture and growth capital firms focused on this sector -- Salix Ventures and HLM Venture Partners - and also worked with Madison Dearborn Partners earlier in his career. He has led investments in and/or served on the Boards of Directors of companies such as TelaDoc (NYSE: TDOC); Change Healthcare (acquired by Emdeon); Aperio (acquired by Leica Biosystems); Titan Health (acquired by United Surgical Partners); US Renal Care (acquired by Leonard Green); Payerpath (acquired by Misys/Allscripts); Vantage Oncology (acquired by McKesson); NovoLogix (acquired by CVS Health); VeriCare (acquired by MedOptions); OnShift; and ClearData Networks. Marty received his AB from Princeton University and his MBA from the Stanford University Graduate School of Business.
Contact Information
Investor Status
Actively Seeking New Investments
Primary Investor Type
Angel (individual)
Primary Office
- Cleveland, OH
- United States
Martin Felsenthal Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialMartin Felsenthal Team (1)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Martin Felsenthal | Angel Investor | 00 | 0 | 0 | Cleveland, OH |